Clinical Trial Detail
| NCT ID | NCT01909453 |
| Title | Study Comparing Combination of LGX818 Plus MEK162 Versus Vemurafenib and LGX818 Monotherapy in BRAF Mutant Melanoma (COLUMBUS) |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase III |
| Variant Requirements | Yes |
| Sponsors | Array BioPharma |
| Indications | |
| Therapies | |
| Age Groups: | adult senior |
CKB BOOST